3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Stroke
1
Recurrence
1
Ovarian Neoplasms
1
Neurologic Manifestations
1
Melanoma
1
Margins of Excision
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Inflammatory Breast Neoplasms
1
Glioblastoma
1
Fallopian Tube Neoplasms
1
Communication
1
Colorectal Neoplasms
1
Caregiver Burden
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Brain Neoplasms
1
Brain Injuries, Traumatic
1
Brain Injuries
1
Advanced Malignant Solid Neoplasm
1
Interventions
fludarabine
11
Cyclophosphamide
10
fludarabine phosphate
8
Whole-Body Irradiation
7
Specimen Handling
7
Cytarabine
7
Biopsy
7
venetoclax
6
Busulfan
6
Azacitidine
6
Mycophenolic Acid
5
Melphalan
5
Injections
5
CPX-351
5
decitabine and cedazuridine drug combination
4
Tacrolimus
4
Peripheral Blood Stem Cell Transplantation
4
Granulocyte Colony-Stimulating Factor
4
Filgrastim
4
Cyclosporine
4
ivosidenib
3
X-Rays
3
Stem Cell Transplantation
3
Magnetic Resonance Spectroscopy
3
treosulfan
2
ruxolitinib
2
luspatercept
2
gilteritinib
2
Sirolimus
2
Photons
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Palliative Care
×
30 days
×
Clear all
No trials found.